Jazz Pharmaceuticals plc
JAZZ
$103.58
$5.805.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 482.20M | 560.12M | 463.16M | 394.92M | 330.79M |
| Total Depreciation and Amortization | 661.56M | 660.07M | 650.85M | 648.18M | 644.72M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 259.93M | 252.44M | 228.45M | 205.98M | 229.38M |
| Change in Net Operating Assets | 154.78M | -76.72M | -177.80M | -175.96M | -166.36M |
| Cash from Operations | 1.56B | 1.40B | 1.16B | 1.07B | 1.04B |
| Capital Expenditure | -45.05M | -38.07M | -34.89M | -28.40M | -27.04M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -360.18M | -470.13M | -178.23M | -573.10M | -403.10M |
| Cash from Investing | -405.22M | -508.20M | -213.11M | -601.50M | -430.14M |
| Total Debt Issued | 980.77M | 980.77M | 980.77M | -- | -- |
| Total Debt Repaid | -1.36B | -606.00M | -606.00M | -31.00M | -31.00M |
| Issuance of Common Stock | 31.60M | 20.65M | 20.30M | 25.80M | 25.73M |
| Repurchase of Common Stock | -387.05M | -369.18M | -466.59M | -391.24M | -326.74M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.72M | -5.72M | -- | -- | -- |
| Cash from Financing | -736.40M | 20.52M | -71.52M | -396.44M | -332.02M |
| Foreign Exchange rate Adjustments | 1.72M | -1.68M | 2.40M | -1.69M | -892.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 418.56M | 906.55M | 882.45M | 73.50M | 275.47M |